The Federal Framework
Testosterone is a Schedule III controlled substance. Under the Ryan Haight Online Pharmacy Consumer Protection Act (2008), prescribing controlled substances normally requires at least one prior in-person medical evaluation.
However, during the COVID-19 public health emergency, the DEA waived this requirement to ensure continuity of care. As these waivers approached expiration, the DEA issued successive extensions. The most recent — a fourth temporary extension — permits DEA-registered practitioners to prescribe Schedule II–V controlled medications via audio-video telehealth encounters without a prior in-person evaluation through December 31, 2026.
This federal framework is what makes online TRT clinics possible. You can legally receive a testosterone prescription via video consultation from a licensed physician without ever visiting their office in person — at least through the end of 2026.
State-Level Variations
While federal law sets the floor, state medical boards can enforce stricter standards. Your provider must hold a valid medical license in the state where you're physically located at the time of consultation, and they must comply with that state's specific telehealth prescribing rules.
Most states allow telehealth TRT prescribing under the current federal framework. However, several states impose additional requirements that affect how online clinics operate.
States With Notable Restrictions
| State | Restriction | Impact on Online TRT |
|---|---|---|
| California | Requires "appropriate prior examination" before internet prescribing | Fully asynchronous (text-only) platforms may not comply; video consultation typically satisfies this requirement |
| Virginia | Prescribing based solely on online questionnaire doesn't meet standard of care | Requires documented synchronous medical evaluation — video call minimum |
| Alabama | Telehealth encounters must meet same standard of care as in-person | Requires thorough documentation and comprehensive clinical evaluation |
| Connecticut | Limits Schedule II–III prescribing to specific conditions via telehealth | May require additional documentation for TRT prescriptions |
| New Jersey | Requires in-person evaluations for Schedule II substances | Testosterone (Schedule III) is generally permissible, but regulations are interpreted conservatively |
This table covers notable restrictions as of March 2026. State telehealth laws are evolving — check with your chosen clinic for current availability in your state.
Which Clinics Serve Your State
Coverage varies by provider:
| Clinic | States Served |
|---|---|
| Maximus Tribe | 48 states |
| TRT Nation | 46 states |
| Peter MD | 45+ states |
| Hone Health | 44 states |
| Marek Health | 40+ states |
| Fountain TRT | 38 states |
If a clinic doesn't serve your state, it's typically because they haven't obtained licensure there or because state-specific regulations make remote prescribing impractical under their clinical model. Our full clinic comparison includes state-by-state availability details.
What's Coming in 2027
The current federal telehealth flexibilities expire December 31, 2026. The DEA is working toward permanent telemedicine prescribing rules — potentially involving a Special Registration for telemedicine providers — but final regulations have not been published as of March 2026.
The industry expects some form of permanent telehealth prescribing framework to replace the temporary extensions, given the massive patient population now relying on telemedicine for ongoing care. However, the specifics — particularly around whether audio-only consultations will remain permissible and whether new in-person requirements will be introduced — remain uncertain.
We'll update this guide as the regulatory landscape evolves. For now, the window for starting online TRT is open through at least the end of 2026.